Ehave, Inc. Challenges CEO Letter to Stockholders, Reports on Important Progress and Outlook for 2021 OTC Marketplaces:EHVVF
By FeliciaF.Rose 1 month ago
MIAMI, Dec. 17, 2020 (Globe NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the "Company"), a
MIAMI, Dec. 17, 2020 (Globe NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the "Company"), a chief of digital therapeutics delivering proof-dependent therapeutic interventions to sufferers, announces that Ben Kaplan, President, Main Executive Officer and Chairman, has issued a letter to Ehave's stockholders. The comprehensive text is as follows:
To My Fellow Stockholders,
Around the course of 2020, Ehave, Inc. has produced significant progress in advancing our strategic approach and hit several milestones in our journey. From a corporate standpoint, we are a fully reporting company with the SEC. We have utilized for OTCQB registration and foresee filing with the Canadian Securities Exchange by the end of the 12 months. The combined attempts of our management group, Board of Administrators, and health care advisory board has resulted in quite a few achievements which includes the next highlights:
Ehave expanded its psychedelic mental health platform to much better provide scientists and clinicians, when also allowing patients to take extra regulate about their psychedelic medical records. The Ehave Dashboard is a information driven platform that has been strategically produced to provide greater conversation amongst health care practitioners and health care vendors. The aggregation of facts and details into a person application has confirmed powerful in streamlining the wellbeing method for both of those people and vendors. The cloud based platform can deliver vital options and abilities to healthcare companies, all though enabling seamless integrations with every thing from electronic health documents (EHRs) to telehealth vendors to psychedelic researchers and clinicians. The Ehave Dashboard has been formulated via many years of testing with psychological health care specialists at 1 of Canada's premier hospitals. In addition to supplying much better outcomes, the proprietary system permits people today to consider command of their actual physical and psychological health and fitness. 2020 marked a initially for our Organization as our information system permitted people to access ground breaking treatment plans to psychological health by furnishing clinicians and pharmaceutical businesses with info that will make the provision of treatment a lot more quickly readily available.
Ehave will make the most of its Dashboard and electronic systems to support psychedelic medicine organizations in the generation of the new paradigm in how mental well being is dealt with. Ehave target patients, health professionals, and scientists to aid them speedily authenticate or release own, confirmed knowledge and give more regulate in circumstances where belief simply cannot be compromised. By using blockchain technological know-how, Ehave can provide its health-related companions an possibility to decrease their administration fees by up to 90%.
Our major concentrate is, and usually has been, bettering psychological health and combatting psychological illness. Just about just one in 5 (19 per cent) U.S. adults knowledge some sort of mental ailment and one grownup in 24 (4.1 p.c) has a really serious mental health issues. Psychological disease is treatable and our mission is to address even those with critical mental illness. Throughout the U.S. overall economy, significant psychological ailment results in $193.2 billion in shed earnings just about every calendar year, while depression and anxiety ailments value the world wide financial system $1 trillion in dropped productivity each and every yr. Suicide is the 10th leading lead to of dying in the U.S. and 90% of people today who died by suicide experienced revealed signs of a psychological wellbeing condition, in accordance to interviews with loved ones, buddies and health-related specialists. When you make strides in serving to individuals with mental health and fitness, you get recognized. We have been continually getting protection about the technological innovation and partnerships we are setting up.
Mycotopia Therapy. Mycotopia Therapy is a wholly-owned subsidiary of Ehave that gives a new paradigm for mental wellness. Our key goal by Mycotopia Therapy is to provide a human working experience of creating a roadmap of ideal thoughts-physique-spirit wellbeing. Our medical practitioners and practitioners are disrupting the landscape by offering certainty on what is going on and what to do about it. Mycotopia Treatment has remodeled into an ecosystem to nurture the progress of therapies employing psychedelics. Ehave, as a result of its Mycotopia Treatment subsidiary, owns 10% of the business that makes the PsyTech Psychedelic Industry Virtual investor Conferences and not long ago announced plans to offer you psychedelic retreats. The psilocybin-guided wellness retreats will be offered in different spots around the globe, and will be supervised by certified health-related pros in a protected, legal, and at ease environment. These retreats will be in conjunction with our lover facilities.
In January, 2020 Ehave introduced the obtain of a 10 % stake in Psychedelitech, Inc. as a result of the Mycotopia Therapy subsidiary. Psychedelitech is the mum or dad enterprise of PsyTech, the world's most acknowledged psychedelic meeting. As a result of a current economical transaction, Psychedelitech is valued at $15 million, making Ehave's expense worthy of $1.5 million. Speakers at the PsyTech Digital Investor Conferences have involved Man Lieberman, Director of Nahana Foundation Liana Gillooly, Founder/Progress Officer at North Star/MAPS David Nikzad, Founder of Orthogonal Thinker Inc./Ei.Ventures Stacey Wallin, Co-Founder and Main Strategy Officer at Numinus Wellness, Inc. Rick Doblin, Ph.D., Founder and Govt Director of the Multidisciplinary Association for Psychedelic Research (MAPS) Todd Shapiro of Purple Light-weight Holland Matthew Johnson, PhD., Professor of Psychiatry and Conduct at Johns Hopkins Christian Angermayer, Founder of ATAI Life Sciences Dr. Rosalid Watts, Medical Psychologist at the Psychedelic Analysis Group at Imperial School London Bruce Linton, Founder, and Former Chairman and Co-CEO of Canopy Expansion Company and Dr. Mark Braunstein, The Hashish Psychiatrist and PsyTech Healthcare Advisor.
Partnership with Id Essential. Ehave not long ago declared it would be delivering blockchain primarily based id verification application for the health care community as a plug-in on its Dashboard. Adopting blockchain technological know-how to Ehave's Dashboard has the prospective to renovate wellbeing treatment, putting the patient at the middle of the overall health care ecosystem and expanding the safety, privacy, and interoperability of overall health facts. Blockchain know-how is producing massive prospects for sufferers, medical professionals, and researchers to access info in new approaches with audit trails and verifiable authentication. On-line ID verification is observing a spike in need pushed by the current pandemic as quite a few professional medical professionals mail their staff to work remotely. In the course of the pandemic there has been a strong surge in demand for videoconferencing communication between clients, providers, experts, and other medical pros. Clinical records and affected person details are nevertheless demanded by regulation to be safe. Patient identification and verification is 1 of the most challenging troubles the health care sector faces all through these turbulent occasions, but it is vital in imparting rapidly and productive healthcare services to individuals. Ehave can present a safe blockchain option to psychedelic clinicians and scientists, as effectively as other clinical professionals.
With a renewed analysis interest in LSD, MDMA, Ketamine, and Psilocybin, and a developing normalization after decades of stigma, psychedelics are swiftly becoming the following therapeutic frontier. Ehave a short while ago introduced the formation of KetaDASH an Intravenous (IV) based mostly, house supply system for sufferers who have been prescribed Ketamine. Ehave procured the tangible and intangible assets of CureDash, which at the moment operates an IV supply platform that will grow to be the backbone of KetaDash. By furnishing the system for medical practitioners to administer Ketamine intravenously to people at dwelling, we feel several extra sufferers will get the procedure they call for. Ketamine is at this time applied to support relieve ache and lets sedatives to be productive at decreased doses, lessening the volume of likely addictive suffering medication necessary soon after particular health care techniques. Ketamine is now currently being examined as a procedure for key depression, while it has not yet been authorised by the Food and drug administration to handle depression. The KetaDASH system will incorporate software package, staffing, protocols, and equipment. Ehave has created a wise and intuitive dashboard for KetaDash from where the consumers and the connected nurses can get in depth insight on how the Ketamine remedy is doing the job. Patients will be equipped to generate a profile, check availability of administering nurses, and plan appointments. People are expending additional time at household and household delivery has come to be additional preferred.
Ketamine was to begin with permitted by the US Meals and Drug Administration (Fda) in 1970 as an anesthetic agent that was administered intravenously or intramuscularly for use in diagnostic and surgical treatments. It is now available generically. Ketamine is now becoming studied as a cure for key depression, nevertheless it has not still been accredited by the Food and drug administration to deal with melancholy. Esketamine (Spravato, Janssen) was accredited by the Fda last year for treatment-resistant melancholy. Esketamine is a medication applied as a basic anesthetic and for remedy-resistant depression. Esketamine is used as a nasal spray or by injection into a vein. Esketamine functions largely as a non-competitive N-methyl-D-aspartate receptor antagonist. Numerous professional medical gurus think Ketamine might have a distinctive probable specifically for most cancers-relevant despair.
Addition of Key Staff. While Ehave has a fairly flat organizational framework, we generally have a have to have for powerful administration and a very well-capable Board. 2020 marked the addition of numerous individuals becoming a member of the Enterprise.
Alfred Farrington II joined our company as the Chief Information Officer. Mr. Harrington's principal aim is exploration and enhancement of higher-efficiency technology products and programs for gathering, examining, and processing efficiency details to offer productive options to age-aged troubles.
Dr. Nithin Krishna, M.D., a neuroscience researcher, joined Ehave's Clinical Advisory Board. As a member of the Company's Health care Advisory Board, Dr. Krishna's main responsibilities will be to guide and recommend the Firm on human trials for its cognitive and psychedelic alternatives.
Victor S. Dorodny, MD, PhD, MPH joined our Advisory Board and will advise Ehave on HIPAA compliance and telemedicine technology. Dr. Dorodny was 1 of the creators of the Overall health Insurance policies Portability and Accountability Act of 1996 (HIPAA). He has served on the Advisory Board of the Affiliation of Healthcare Director of Facts Units and is the Previous President of the Western Division of the Nationwide Affiliation of Managed Treatment Physicians. Dr. Dorodny has served in an government potential of quite a few organizations where he has held the title of Main Medical Info Officer, Main Scientific Advisor, and Main Health care Officer.
Russell Schachar, MD, FRCP(C) joined Ehave as Chief Medical Officer. Dr. Schachar is a practising little one and adolescent psychiatrist, Professor in the Office of Psychiatry at the College of Toronto, and Senior Scientist in the Investigate Institute at the Medical center for Ill Children in Toronto, Canada in which he holds the TD Bank Chair in Boy or girl and Adolescent Psychiatry and heads a cognitive neurosciences laboratory which focuses on psychiatric diseases of childhood and adolescence.
Dr. Manideep Reddy (MD,MBA) is a alternative focused medical professional and healthcare expert experienced in working with client, federal government and organization going through projects. His modern engagements involve location up a Molecular genetics undertaking, telemedicine infrastructure for healthcare facility chain in Singapore and Malaysian market place, compliance and distribution infrastructure for neuroscience remedies, molecular commercialization exit pathways for its generic molecules in cardiopulmonary and rheumatological ailments, and the agreement producing amenities across 5 areas in India to manufacture the generic molecules for immunological and dermatological ailments.
As I stated, we are delighted with our progress to day and are extremely energized about our momentum and Ehave's future prospective customers. I would like to thank our staff, partners, and Advisory Board for their fantastic efforts and motivation, and our investors for their ongoing support. We glimpse forward to a powerful 2021.
Supplemental Ehave Inc. Info
We are genuinely grateful for the assist of EHVVF shareholders! Remember to be part of the conversation on our Ehave supporter's telegram team at https://t.me/EhaveInc.
The firm diligently posts essential information and facts and updates by way of weekly video clips from the official business YouTube channel https://www.youtube.com/channel/UCnyW1mgMd0qmYkEMq3O6FWA.
Be sure to abide by Ehave on Twitter @Ehaveinc1
About Ehave, Inc.
Ehave, Inc. (EHVVF) is a chief of electronic therapeutics providing proof-dependent therapeutic interventions to individuals. Our most important emphasis is on strengthening the common treatment in therapeutics to prevent or treat brain ailments or conditions by way of the use of digital therapeutics, independently or jointly, with remedies, gadgets, and other therapies to enhance affected person treatment and health results. Our main products is the Ehave Telemetry Portal, which is a psychological wellbeing informatics system that enables clinicians to make goal and smart selections by means of knowledge insights. The Ehave Infinity Portal delivers a highly effective device understanding and artificial intelligence system with a rising established of state-of-the-art instruments and applications created by Ehave and its primary partners. This empowers individuals, healthcare vendors, and payers to address a huge selection of ailments as a result of large high quality, risk-free, and successful info-driven involvement with clever and obtainable applications. For a lot more information and facts pay a visit to: www.ehave.com.
Forward-Seeking Statement Disclaimer
This push release incorporates "forward-on the lookout statements" inside of the this means of the Non-public Securities Litigation Reform Act of 1995. These statements may well be preceded by the terms "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or identical words and phrases. Ahead-looking statements are dependent on specific assumptions and are issue to a variety of recognised and unidentified risks and uncertainties, several of which are beyond the Firm's handle, and are not able to be predicted or quantified and for that reason, genuine effects could differ materially from those people expressed or implied by this sort of forward-hunting statements: (i) the initiation, timing, progress and final results of the Company's analysis, production and other advancement initiatives (ii) the Company's potential to advance its goods to properly full advancement and commercialization (iii) the production, enhancement, commercialization, and marketplace acceptance of the Company's goods (iv) the lack of sufficient funding to finance the products enhancement and enterprise functions (v) competitive organizations and technologies in the Company's field and introduction of competing solutions (vi) the Company's potential to build and keep company collaborations (vii) loss of critical administration personnel (viii) the scope of protection the Business is ready to establish and maintain for intellectual assets legal rights covering its items and its means to work its business enterprise with out infringing the intellectual house rights of other people (ix) probable failure to comply with relevant wellness info privacy and stability laws and other point out and federal privacy and security guidelines and (x) the issues of predicting steps of the United states Fda and its restrictions. All forward-wanting statements included in this press launch are created only as of the day of this press launch. The Corporation assumes no obligation to update any published or oral ahead-wanting statement except essential by legislation. Far more specific information about the Corporation and the possibility factors that may well impact the realization of forward-on the lookout statements is contained underneath the heading "Danger Things" in Ehave, Inc.'s Registration Statement on Form F-1 filed with the Securities and Exchange Fee (SEC) on September 24, 2015, as amended, which is accessible on the SEC's site, http://www.sec.gov.
For Trader Relations, make sure you get hold of:
Gabe Rodriguez
Tags: CEO, Challenges, Ehave, Important, Letter, MarketplacesEHVVF, OTC, Outlook, Progress, Reports, Stockholders
Previous Maritime On the net and Panama Embassy Formally Launch World's 1st On the internet Portal
Next Denied a Home loan? How to Get Back in the Sport
Amplify Brand Initial, Develop Backlinks 2nd
Food and drug administration Grants Precedence Evaluation to Therapy for Resected Esophageal or Gastroesophageal Junction Cancer
CRM Method Automates Workflows for Vehicle Huge in the Center East
Board remembers Goodwin solicits curiosity in open seat | Information
Why Software Developers Must Offer Licensees With Computer software Escrow Products and services